«ΨΥΧΟΛΟΓΙΑ έρευνα & εφαρμογές» Τόμος 1, Τεύχος 3, 2018 ISSN: 2623-3673
8. Genet Med. Author manuscript; available in PMC 2012 Jun 1.Published in final
edited form as: Genet Med. 2011 Dec; 13(12): 987–995. PMID: 22095251
Personalizing medicine with clinical pharmacogenetics Stuart A. Scott, PhD
9. U.S. National Library of Medicine ABCB1 geneATP binding cassette subfamily B
member 1 RefSeq, Feb 2017
10. U.S. National Library of Medicine DRD2 gene dopamine receptor D2 RefSeq,
Jul 2008
11.
DRD3
dopamine
receptor
www.ncbi.nlm.nih.gov/gene/1814
D3
[
Homo
sapiens
(human)
]
12. Med Sci Monit. 2011; 17(9): RA215–RA220. Dopamine D4 receptor gene DRD4
and its association with psychiatric disorders Radek Ptáček, Hana Kuželová, and
George B. Stefano
13. Hum Genomics. 2009; 3(3): 257–274. Pharmacogenetics of antidepressant
response: An update Antonio Drago, Diana De Ronchi, Alessandro Serretti
14. Pharmacogenetics and Individualized Therapy Anke-Hilse Maitland-van der
Zee, Ann K. Daly , John Wiley & Sons, 2 Αpr 2012
15. Pharmacogenomics. 2014 Apr;15(6):869-84. Pharmacogenetics of second-
generation antipsychotics,Brennan MD
16. Expert Opin Drug Metab Toxicol. Expert Opin Drug Metab Toxicol. 2013 Feb;
9(2): 183–191.Pharmacogenetics of Antipsychotics: Recent Progress and
Methodological Issues Jian-Ping Zhang, MD, PhD and Anil K. Malhotra, MD
17. Role of Pharmacogenomic Biomarkers In Predicting and Improving Drug
Response Part 1: The Clinical Significance of Pharmacogenetic Variants P T. 2013
Sep; 38(9): 545-551, 558-560.
18. J Adv Pharm Technol Res. 2010 Oct-Dec; 1(4): 423–424. Pharmacogenetics:
The future medicine, Rajiv Saini, Santosh Saini, and R. S. Sugandha
19. Pharmacogenetics and pharmacogenomics: origin, status, and the hope for
personalized Medicine W Kalow Department of Pharmacology, University of
Toronto, Toronto, Canada, The Pharmacogenomics Journal (2006) 6, 162–165
20. Pharmacogenomics J. 2015 Oct; 15(5): 461–466. Establishing the
characteristics of an effective pharmacogenetic test for clozapine-induced
agranulocytosis M Verbelen, D A Collier,D Cohen, J H MacCabe, and C M Lewis
21. The CATIE schizophrenia trial: results, impact, controversy. Manschreck TC1,
Boshes RA. Harv Rev Psychiatry. 2007 Sep-Oct;15(5):245-58.
22. What CATIE Found: Results From the Schizophrenia Trial Dr. Marvin S. Swartz,
M.D., T. Scott Stroup, M.D., M.P.H., Dr. Joseph P. McEvoy, M.D., Dr. Sonia M.
Davis, Dr.P.H., Dr. Robert A. Rosenheck, M.D., Dr. Richard S. E. Keefe, Ph.D., Dr.
John K. Hsiao, M.D., and Dr. Jeffrey A. Lieberman, M.D. Psychiatr Serv. 2008 May;
59(5): 500–506.